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The evolutionarily conserved MAP kinase (MAPK) cascades play essential roles in plant and animal
innate immunity. A recent explosion of research has uncovered a myriad of virulence strategies used
by pathogenic bacteria to intercept MAPK signaling through diverse type III effectors injected into
host cells. Here, we review the latest literature and discuss the various mechanisms that pathogenic
bacteria use to manipulate host MAPK signaling cascades.Introduction
Plants and animals are constantly exposed to awide range
of microbes and have evolved sophisticated immune
systems to defend against potential pathogens. Innate im-
munity, the first line of host defense, is triggered instanta-
neously upon the detection of conserved pathogen- or mi-
crobe-associatedmolecular patterns (PAMPs orMAMPs).
The recognition of different MAMPs by specific pattern-
recognition receptors (PRRs) activates defense responses
that are important for host immunity to both pathogenic
and nonpathogenic microbes (Akira et al., 2006; Ausubel,
2005; Chisholm et al., 2006; He et al., 2007; Jones and
Dangl, 2006; Meylan et al., 2006). The early immune re-
sponses activated by different MAMPs, such as bacterial
flagellin, lipopolysaccharide, and peptidoglycan, include
the activation of mitogen-activated protein kinase (MAPK)
signaling cascades and transcriptional reprogramming in
plants and animals. (Akira et al., 2006; Ausubel, 2005;
Dong et al., 2002; He et al., 2007; Nu¨rnberger et al.,
2004). A MAPK signaling cascade generally involves three
functionally tiered protein kinases, a MAPK kinase kinase
(MAPKKK/MEKK/MTK), a MAPK kinase (MAPKK/MEK/
MKK), and a MAP kinase (MAPK/MPK), that transduce
and amplify extracellular and intracellular stimuli into a
wide range of overlapping or specific intracellular re-
sponses in eukaryotic cells. MAPKKKs are the conserved
entry point of MAPK cascades and are regulated by
upstream signals through diverse receptors, adaptors,
and signaling molecules. In mammals, Toll-like receptors
(TLRs) play prominent roles in the activation of MAPK sig-
naling in response to MAMPs (Akira et al., 2006; Ausubel,
2005; Dong et al., 2002). In plants, leucine-rich repeat re-
ceptor-like kinases (LRR-RLK) act upstreamofMAPKcas-
cade in innate immune responses (Gomez-Gomez and
Boller, 2000; Zipfel et al., 2006). Transcription factors are
important substrates of MAPKs, throughwhichMAPK sig-
naling cascades regulate gene expression in response to
stimuli. Several informative reviews have provided com-
prehensive insights into MAPK cascades that regulate
diverse cellular activities and control plant and animal de-
velopment, growth, survival, cell death, and immunity(Chang and Karin, 2001; Dong et al., 2002; Nakagami
et al., 2005; Pedley and Martin, 2005; Tena et al., 2001;
Zhang and Klessig, 2001).
Many Gram-negative bacteria inject a repertoire of vir-
ulence effector proteins into host cells through type III
secretion system (T3SS) to manipulate host immunity
and promote pathogenicity (Alfano and Collmer, 2004;
Galan and Wolf-Watz, 2006; Grant et al., 2006; He et al.,
2004; Mudgett, 2005; Navarro et al., 2005). Although the
structural components of T3SS are relatively conserved,
the sequences and functions of individual effectors se-
creted from T3SS can be highly divergent in different spe-
cies of plant and animal pathogenic bacteria. Some spe-
cies, such as Yersinia of animal pathogens, secrete just
a few effectors, whereas Pseudomonas species of plant
pathogens deliver more than 30 effectors (Lindeberg
et al., 2006; Navarro et al., 2005). Different effectors
suppress host immunity through overlapping or distinct
molecular actions (Abramovitch et al., 2006; Alfano and
Collmer, 2004; Galan and Wolf-Watz, 2006; Grant et al.,
2006; Mudgett, 2005; Navarro et al., 2005; Nomura
et al., 2005; Stebbins and Galan, 2001). Recent findings
have uncovered novel strategies and biochemical activi-
ties used by various type III effectors to target the evolu-
tionarily conservedMAPK signaling cascades. This review
aims to provide a timely overview of this specific aspect by
following the sequence of host MAPK cascade modules
from the latest discoveries on the inhibition of downstream
MAPKs to the suppression of their upstream regulators,
namely MAPKKs and MAPKKKs.
Inhibiting MAPKs by Bacterial Effectors
of Animal Pathogens
Shigella species are intracellular bacterial pathogens that
cause bacillary dysentery in humans by infecting colonic
epithelial cells. In intestinal epithelial cells, recognition of
bacterial MAMPs bymammalian cell-surface or intracellu-
lar PRRs activates proinflammatory signaling pathways,
including MAPKs and transcription factor NF-kB, which
leads to the expression of cytokines and chemokines
(Akira et al., 2006; Meylan et al., 2006). There are at leastCell Host & Microbe 1, May 2007 ª2007 Elsevier Inc. 167
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ReviewFigure 1. Homologous Effectors with
Similar or Distinct Functions in
Manipulating Host Innate Immunity
(A) Homologous OspF, SpvC, and HopAI1 de-
phosphorylate MAPKs with similar phospho-
threonine lyase activity. Phosphothreonine
lyase activity of SpvC is deduced from se-
quence homology and its MAPK dephosphory-
lation activity.
(B) Homologous YopJ, VopA, and AvrA have
distinct host targets in suppressing immune
responses.three major families of MAPKs in mammals: the extracel-
lular signal-regulated protein kinases (ERK), the p38 ki-
nases, and the c-Jun NH2-terminal kinases (JNK) (Chang
and Karin, 2001; Dong et al., 2002). All MAPKs contain
a conserved Thr-X-Tyr motif within their activation loop,
and the phosphorylation of both Thr and Tyr is essential
for their activation. Several independent studies now pro-
vide compelling evidence that a Shigella type III effector,
OspF, directly targets and inhibits MAPK activities to pro-
mote infection (Arbibe et al., 2007; Kramer et al., 2007;
Li et al., 2007).
Using Shigella flexneri infection assays in HeLa and
Caco-2 cells, Arbibe et al. (2007) show that OspF inacti-
vates MAPKs, ERK1/2, and p38, thereby preventing the
phosphorylation of a critical Ser in histone H3 (H3pS10)
that is required for the transcription of a subset of NF-kB-
regulated genes. By analyzing a series of Shigella deletion
mutants, OspF was found to be essential for the inactiva-
tion of ERKs and p38. OspF accumulates in the nucleus
of HeLa cells within 15 min of Shigella infection, which is
consistent with the nuclear accumulation of ERKs in a de-
phosphorylated form after Shigella infection. However,
since there is no obvious nuclear localization signal in
OspF, the mechanism by which OspF enters the nucleus
and whether the nuclear retention of OspF is required for
its activity remains to be determined. Through dephos-
phorylation of MAPKs, OspF downregulates the expres-
sion of a subset of MAPK-dependent genes. Although
OspF does not directly block the activation of the IkB ki-
nase-NF-kB pathway, it selectively represses the expres-
sion of NF-kB-dependent genes encoding chemokines,
e.g., IL8. OspF inhibits MAPK-mediated H3pS10, thus
blocking the recruitment of transcription machinery com-
ponents including transcription factor NF-kB and RNA
polymerase II at the selected IL8 promoter. The selective
repression of NF-kB targets by OspF suggests that
Shigellamayhave evolved the ability to preciselymodulate
the immune responses rather than nonspecifically shutting
themdown. Perhaps some aspects of the host immune re-
sponses are beneficial for the dissemination of the patho-
gen, and it might be productive for Shigella to incorporate
selectivity in repressingNF-kB target genes. It will be inter-
esting to decipher the logic of this selective repression168 Cell Host & Microbe 1, May 2007 ª2007 Elsevier Inc.and the precise mechanism by which OspF achieves its
narrow specificity.
Contrary to the proposed mode of OspF action as
a dual-specificity phosphatase (Arbibe et al., 2007), using
tandem mass spectrometry analysis with recombinant
protein, Li et al. (2007) make the surprising discovery
that OspF functions as a phosphothreonine lyase in the
suppression of MAPK activity. OspF cleaves the C-OP
bond in the phosphothreonine residue in the activation
loop to irreversibly inactivate MAPKs. Different from a
protein phosphatase, phosphothreonine lyase produces
a modified Thr residue without a free hydroxyl group.
This chemical modification prevents the rephosphoryla-
tion of the Thr residue by kinases. Significantly, several
members of the OspF family, including SpvC from an an-
imal pathogen Salmonella (Li et al., 2007) andHopAI1 from
a plant pathogen Pseudomonas syringae (Li et al., 2007;
Zhang et al., 2007), also dephosphorylate MAPKs, proba-
bly through the same phosphothreonine lyase activity
(Figure 1A). Phosphothreonine lyase activity has not been
reported previously. A recurrent characteristic of bacterial
type III effector function is to mimic the function of host
proteins (Alto et al., 2006; Galan and Wolf-Watz, 2006;
Stebbins and Galan, 2001). It is possible that phospho-
threonine lyase activity may also be a commonly used
eukaryotic mechanism to irreversibly dephosphorylate
kinases or other phosphorylated substrates.
In a third recently published study using yeast as a sur-
rogate host, Kramer et al. (2007) show that OspF targets
the yeast cell wall integrity pathway, a highly conserved
MAPK signaling pathway. The finding is enabled by com-
bining sophisticated yeast functional genomic screens,
statistical data mining, and microarray analysis. Expres-
sion of OspF inhibits phosphorylation of all tested yeast
MAPKs, including SLT2, HOG1, KSS1, and FUS3. How-
ever, when tested in HeLa cells after Shigella infection,
OspF specifically inhibits phosphorylation of ERK and
p38, but not JNK. Similar to the results of Arbibe et al.
(2007), Kramer et al. (2007) find that inhibition of MAPK
signaling by OspF attenuates the host immune responses
to Shigella infection, particularly recruitment of polymor-
phonuclear leukocytes to the infected tissues in mouse
and rabbit animal models.
Cell Host & Microbe
ReviewThere are some contradictory data in the studies by Li
et al. (2007) and by Arbibe et al. (2007). Arbibe et al.
(2007) report that OspF specifically dephosphorylates
ERK1/2 and p38 in vivo and in vitro, but not JNK, while Li
et al. (2007) show that OspF dephosphorylates all three
families of MAPKs in vitro. An independent study by
Kramer et al. (2007) supports the specificity of OspF
inhibition in ERK and p38 activation in HeLa cells infected
with Shigella. The conflicting observations may be due to
the different experimental conditions and OspF overex-
pression, since a significantly higher amount of OspF is re-
quired to dephosphorylate JNK than p38 (Li et al., 2007).
Intriguingly, in an earlier report, Zurawski et al. (2006)
show that OspF promotes, rather than blocks, phosphory-
lation of ERK1/2 in the polarized T84 cells 3 hr afterShigella
infection. Besides different hosts and bacterial strains
used, the conflicting results may be mainly caused by the
different time points, 30 min versus 3 hr, for detection of
phosphorylated MAPKs, which can be activated by multi-
ple signals for distinct functions in different subcellular
compartments. Alternatively, OspF may play dual roles in
manipulating MAPK activity at different infection stages.
To ultimately resolve the detailed molecular actions of
OspF, it is important to determine its expression dynam-
ics, subcellular localization, and quantity in physiological
conditions during Shigella infection in cells or animal
models.
Modulating MAPKs by Bacterial Effectors
of Plant Pathogens
Most type III effectors of plant and animal pathogens do
not share obvious sequence similarity to eukaryotic pro-
teins. However, some effectors of plant pathogens have
putative homologs in animal pathogens. It remains mostly
unknown whether these homologs from plant and animal
pathogens share conserved molecular actions in promot-
ing pathogenicity. Now, Zhang et al. (2007) suggest that
HopAI1, a conserved effector from Pseudomonas syrin-
gae strains and a homolog of OspF, also acts as a phos-
phothreonine lyase (Figure 1A) that removes the phos-
phate group from phosphothreonine to inactive MAPKs.
Shown by in vitro pull-down and in vivo coimmunoprecipi-
tation assays, HopAI1 directly interacts with two Arabi-
dopsis MAPKs, MPK3 and MPK6. In plants, several
MAPKs are quickly activated by a conserved 22 amino
acid peptide (flg22) from P. syringae flagellin (Asai et al.,
2002). Overexpression of HopAI1 in transgenic Arabidop-
sis plants or in mesophyll cells suppresses endogenous
MPK3 and MPK6 activation by flg22. In overexpression
experiments, the ratio of HopAI1 to MAPK protein level
may be critical for HopAI1 suppressor activity, since
HopAI1 does not inhibit flg22-induced MAPK activation
when HopAI1 and MAPK are expressed under the same
promoter in the mesophyll cell transient expression as-
says (He et al., 2006). MPK3 and MPK6 are activated by
many biotic and abiotic stresses (Nakagami et al., 2005).
It is likely that HopAI1 can also block the activation of
MPK3 and MPK6 by other signals in addition to flg22.
OspF specifically inactivates ERK and p38, but not JNK(Arbibe et al., 2007; Kramer et al., 2007). It will be inter-
esting to learn whether HopAI1 also specifically dephos-
phorylates MPK3 and MPK6, but not other MAPKs in
Arabidopsis.
Expression of HopAI1 in Arabidopsis plants blocks all
tested flg22-induced responses, including activation of
defense genes, production of reactive oxygen species
(ROS), and deposition of callose. These responses may
function downstream or in parallel to MAPK activation in
flg22-induced signaling. In contrast, OspF only sup-
presses a small subset of MAPK- and NF-kB-activated
genes by comparing the transcriptome changes in mam-
malian cells infected with wild-type or ospF mutant
Shigella strains (Arbibe et al., 2007). The identification of
direct MAPK target genes in Arabidopsis will reveal the
specificity of HopAI1 in the inactivation of MAPKs. Since
the effect of HopAI1 is very broad, it may also act on addi-
tional substrates besides MAPKs. Unlike in mammals, no
histone phosphorylation role for Arabidopsis MAPKs in-
side the nucleus has been reported yet. Understanding
MAPK functions in plant innate immunity may help un-
cover virulence mechanisms of bacterial type III effectors.
Although HopAI1 does not seem to function as a virulence
effector inP. s. tomatoDC3000, amodel virulent pathogen
in Arabidopsis and tomato (Lindeberg et al., 2006), it con-
tributes to pathogenicity of P. s. tomato 0288-9 in tomato
(Zhang et al., 2007). This may be a result of specific adap-
tation during host and microbe coevolution and adds
another layer of complexity in deciphering the precise
functions of type III effectors.
HopPtoD2, another effector from P. s. tomato, has
in vitro protein tyrosine phosphatase activity and a con-
served catalytic Cys residue is required for its activity
(Bretz et al., 2003; Espinosa et al., 2003). Transient over-
expression of HopPtoD2 in tobacco suppresses the cell
death induced by an active tobacco MKK, NtMEK2DD.
This cell death suppression function of HopPtoD2 requires
the conserved catalytic Cys residue (Espinosa et al.,
2003). It is likely that HopPtoD2 promotes pathogenicity
through inactivation of MAPK signaling. However, since
HopPtoD2 is unable to suppress flg22-induced MAPK
activation in Arabidopsis mesophyll cells (He et al., 2006),
it remains unknown whether the effects of HopPtoD2 on
MAPK are a direct consequence of dephosphorylating
MAPKs through its tyrosine phosphatase activity. Intrigu-
ingly, like HopPtoD2, many type III effectors of plant bac-
terial pathogens could suppress immunity-associated cell
death triggered by pathogen effectors or other signals
(Abramovitch et al., 2006; Alfano and Collmer, 2004; Grant
et al., 2006; Mudgett, 2005). It will be interesting to test the
ability of more type III effectors in modulating MAPK
signaling, which has been shown to regulate immunity-
associated cell death in plants (Pedley and Martin, 2005;
Zhang and Klessig, 2001).
Targeting and Interfering with MAPKKs
YopJ is a conserved type III effector protein of Yersinia
species that disrupts host immune responses by inhibiting
both theMAPKandNF-kBsignalingpathways. YopJbindsCell Host & Microbe 1, May 2007 ª2007 Elsevier Inc. 169
Cell Host & Microbe
Reviewdirectly tomultipleMAPKKsand theupstreamkinase in the
NF-kB pathway, IkB kinase b (IKKb), to prevent their acti-
vation (Orth et al., 1999). Based on the sequence and
structure prediction, it is suggested that YopJ functions
as a cysteine protease (Figure 1B), although the recombi-
nant YopJprotein does not possess in vitro protease activ-
ity (Orth et al., 2000). It appears that YopJ may not cleave
MAPKKs directly, since the presence of YopJ does not no-
ticeably change themigration pattern ofMAPKKs on SDS-
PAGE. Using the highly sensitive mass spectrometry and
liquid chromatography analyses, Mukherjee et al. (2006)
show that YopJ acetylates the recombinant human
MAPKK6 on Ser and Thr residues in the activation loop.
YopJ is an acetyltransferase that transfers acetyl from
acetyl-CoA to MAPKK in vitro. The acetylation of MAPKKs
on the conserved Ser and Thr residues byYopJmay inhibit
these residues from being further phosphorylated by
upstream MAPKKKs.
In a parallel study, Mittal et al. (2006) have observed that
a specific peptide antibody against the activation loop of
MEK2, a MAPKK upstream of ERK1/2, cannot detect the
MEK2 protein in cells expressing YopJ. Since YopJ does
not affect the stability of MEK2, it is hypothesized that
YopJ may covalently modify MEK2, thereby masking the
epitope for its antibody recognition. Mass spectrometry
analyses reveal that YopJ causes acetylation of two Ser
residues in the activation loop of MEK2. YopJ also acety-
lates a conserved Thr residue in the activation loop of both
IKKa and IKKb (Mittal et al., 2006). In addition, YopJ spe-
cifically acetylates one Ser residue in the kinase domain
and one Thr residue near the carboxyl terminus of IKKa.
These two residues are not conserved in IKKb, and the
significance of this modification is not known. Future stud-
ies may eventually uncover how YopJ determines its sub-
strate specificity. The finding that YopJ can function as an
acetyltransferase may have broader impact because
YopJ homologs with similar catalytic residues have also
been found in Salmonella (AvrA), Vibrio (VopA) (Figure 1B),
and plant bacterial pathogen Xanthomonas (AvrBsT) (Orth
et al., 2000; Trosky et al., 2004). AvrBsT does not seem
to inhibit the flg22-induced MAPK activation when ex-
pressed in Arabidopsis mesophyll cells (He et al., 2006).
Interestingly, instead of inhibiting immunity, AvrBsT trig-
gers potent immune responses, including programmed
cell death. The conserved catalytic residues are required
for AvrBsT-induced cell death (Orth et al., 2000). It remains
to be determined whether AvrBsT also functions as an
acetyltransferase to trigger plant immunity. By blocking
the NF-kB pathway, YopJ inhibits the synthesis of antia-
poptotic factors and promotes the induction of apoptosis,
thereby contributing to Yersinia pathogenicity (Orth et al.,
1999).
It has been shown previously that YopJ inhibits conju-
gation of SUMO-1, a ubiquitin-like protein, to the target
proteins in mammalian cells (Orth et al., 2000). YopJ has
also been found to function as a deubiquitinase in vitro
and to inhibit proteasomal degradation of IkBa (Zhou
et al., 2005). It seems that the catalytic cysteine residue
is required for YopJ inhibition function in MAPKK activa-170 Cell Host & Microbe 1, May 2007 ª2007 Elsevier Inc.tion, sumoylation, and ubiquitination. It remains unclear
whether YopJ targets MAPKKs for deubiquitination or
whether YopJ has different host targets for its acetyltrans-
ferase and deubiquitinase activities. Together, these stud-
ies suggest that YopJ may be a multifunctional enzyme
that is involved in diverse cellular processes (Figure 1B).
Suppressing MAPK Signaling at or Upstream of
MAPKKKs
SptP, an effector from Salmonella, has been shown to in-
hibit ERK activation by interfering with Raf-1, a MAPKKK
(Lin et al., 2003). In a series of kinase and reporter assays
with various constitutively active MAPK cascade compo-
nents, SptP inhibits active Raf-1-, but not MEK1/2-
induced gene induction andERK activation. SptP contains
two functionally independent domains: an amino-terminal
domain with GTPase-activating protein (GAP) activity and
a carboxy-terminal domain with tyrosine phosphatase
activity (Stebbins and Galan, 2001), and both domains
are required for its inhibition of ERK activation by active
Raf (Lin et al., 2003). However, it is unclear whether SptP
directly targetsRaf to inactivate its kinase activity or blocks
Raf-mediated MEK activation. The physiological role of
Raf in mammalian innate immunity remains to be defined.
In plants, different MAMPs are usually perceived by dis-
tinct cell-surface PRRs and activate convergent intracellu-
lar signaling pathways (Ausubel, 2005; Chisholm et al.,
2006; Jones and Dangl, 2006; He et al., 2007). However,
in response to pathogenic bacterial infection, MAMP-trig-
gered early defense gene transcription is actively sup-
pressed in a T3SS-dependent manner (He et al., 2006).
This observation suggests that type III effectors frompath-
ogenic bacteria could suppress MAMP-triggered immu-
nity. Applying a cell-based genetic screen, AvrPto and
AvrPtoB from P. s. tomato have been identified as potent
suppressors of MAMP-triggered early defense gene
transcription and MAPK activation. AvrPto and AvrPtoB
suppress the convergent signaling activated by multiple
MAMPs from different microorganisms, including harpin
and NLP/NPP1 (He et al., 2006; Nu¨rnberger et al., 2004).
Epistasis analysis with constitutively active MAPKKs and
MAPKKK suggests that AvrPto and AvrPtoB suppress
MAMP-triggered signaling upstream of MAPKKK in the
MAPK cascade (Figure 2A).
Consistent with the cell-based assays, the inducible ex-
pression of AvrPto or AvrPtoB in transgenic Arabidopsis
plants also blocks flg22 signaling (de Torres et al., 2006;
He et al., 2006). In tobacco leaves, transient expression
of AvrPto or AvrPtoB inhibits flg22-mediated MAPK acti-
vation and ROS production (Hann and Rathjen, 2007).
The signaling components downstream of MAMP recep-
tors and upstream of MAPK cascade are largely unknown
in plant MAMP-triggered immunity. The identification of
host targets of AvrPto and AvrPtoB will help elucidate
the conserved mechanism used by multiple MAMPs to
transduce signals from receptors to the convergent
MAPK cascade (He et al., 2006). Importantly, deletion of
AvrPto and AvrPtoB from a pathogenic bacterium signifi-
cantly reduces its virulence in Arabidopsis, suggesting
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Share Overall Sequence Homology but
Have Overlapping and Distinct Functions
in Plant Innate Immunity
(A) AvrPto and AvrPtoB block MAMP-triggered
immunity and MAPK signaling cascade in
Arabidopsis. The N terminus of AvrPtoB
(N-AvrPtoB) is required for the suppression
activity.
(B) The C terminus of AvrPtoB (C-AvrPtoB) acts
as an E3 ubiquitin ligase to block effector-
triggered immunity in tomato and tobacco.
(C) AvrPto and AvrPtoB activate effector-trig-
gered immunity and MAPK signaling cascade
through the plant resistance genes Pto and
Prf in tomato. The N terminus of AvrPtoB
(N-AvrPtoB) is essential for this activity.that AvrPto and AvrPtoB contribute to bacterial pathoge-
nicity with in vivo bacterial infection assay (He et al., 2006).
In addition, the introduction of AvrPtoB into P. s. phaseo-
licola promotes its virulence in Arabidopsis and bean (de
Torres et al., 2006).
Future Challenges
MAPK cascades are evolutionarily conserved signaling
regulators and are essential components in plant and ani-
mal immunity (Ausubel, 2005; Dong et al., 2002; Pedley
and Martin, 2005; He et al., 2007; Nu¨rnberger et al.,
2004). Many pathogenic bacteria have evolved distinct
type III virulence effectors to manipulate host MAPK
signaling cascades to promote pathogenicity. These viru-
lence effectors appear to have acquired diverse biochem-
ical activities and target different modules of MAPK cas-
cades in host immunity (Figure 3 and Table 1).
Most type III effectors share no obvious sequence sim-
ilarity to proteins with known functions in eukaryotes. It
has been very challenging to predict the biological and
biochemical functions of effectors solely based on amino
acid sequences. Structure analysis can provide valuable
clues for the function of some effectors (Janjusevic
et al., 2006; Stebbins and Galan, 2001). However, under-
standing the function of most effectors will require versa-
tile and quantitative assays, the determination of their sub-
cellular localization and expression dynamics, and the
identification of host targets. The examples presented in
this review suggest that pathogens have deployed a set
of novel genes to interfere with host cellular functions
and processes rather than simply hijacking eukaryotic
genes through horizontal gene transfer. Moreover, some
effectors are chimeric proteins that possess multiple do-
mains with separate virulence functions. For example,
the N-terminal domain of AvrPtoB from Pseudomonas
shows similar suppressor function with AvrPto in flg22-
induced signaling, although AvrPto and AvrPtoB do not
share overall sequence homology (Figure 2A) (He et al.,
2006). The C-terminal domain of AvrPtoB is structurallysimilar to the U box and RING finger components of E3
ubiquitin ligases and can block cell death in plants and
yeast (Figure 2B) (Janjusevic et al., 2006). In addition to
their virulence functions in blocking the two types of innate
immune responses, AvrPto and AvrPtoB can also activate
potent effector-triggered immune responses in the pres-
ence of specific disease resistance genes, Pto and Prf in
tomato and tobacco (Figure 2C) (Pedley and Martin,
2005). Effectors with dual and opposite functions in innate
immune responses may be the consequence of unique
plant-bacteria coevolution. SptP from Salmonella is also
a virulence effector with multiple domains and different
functions (Lin et al., 2003; Stebbins and Galan, 2001). In
addition, some pathogens have developed specific viru-
lence strategies to cope with certain hosts during coevo-
lution. For instance, type III effectors from plant pathogens
can modulate plant hormone biosynthesis and signaling
pathways or chloroplast structures to evade plant immu-
nity (de Torres-Zabala et al., 2007; Jelenska et al., 2007).
Future studies will certainly uncover novel functions of
bacterial effectors in their interceptions of host immunity,
and perhaps new signaling mechanisms in eukaryotes.
Evidence from bacterial genome sequences and bioin-
formatics suggests that some putative effectors from var-
ious plant and animal pathogens share certain conserved
sequences/motifsor invariant residues.These familymem-
bers may share similar biochemical activities, molecular
functions, and host targets (Alto et al., 2006; Li et al.,
2007; Orth et al., 2000; Rohde et al., 2007; Shao et al.,
2002; Zhang et al., 2007). For example, OspF and HopAI1
possess the same enzymatic activity to inactivate similar
host proteins (Figure 1A; Table 1). However, this may not
be generalized for other effector families. YopJ family
members include AvrA fromSalmonella, VopA from Vibrio,
and AvrBsT from Xanthomonas andmodulate overlapping
or distinct host signaling pathways (Figures 1B and 3). It
is well documented that YopJ inhibits both MAPK and
NF-kB pathways. AvrA inactivates the NF-kB pathway
downstream of IKKb but not the MAPK pathwayCell Host & Microbe 1, May 2007 ª2007 Elsevier Inc. 171
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Innate immunity is triggered by recognition of pathogen- or microbe-associated molecular patterns (PAMPs/MAMPs), such as flagellin, lipopolysac-
charide, and peptidoglycan, and activates evolutionary conserved signaling pathways, including MAPK cascades, in plants and mammals. The ac-
tivation of MAPK cascades induces the expression of downstream transcription factors (TFs), thereby activating immune response genes for host
immunity. Pathogenic bacteria inject a set of virulence effectors into host cells through type III secretion system (T3SS) to promote pathogenicity
by targeting different MAPK cascade components. In plants, different PAMPs/MAMPs are usually perceived by cell-surface receptors with extracel-
lular leucine-rich repeats and intracellular kinase domain (LRR-RLK). AvrPto and AvrPtoB from Pseudomonas syringae suppress MAPK cascade up-
stream of MAPKKK; HopAI1 from P. syringae inactivates MAPKs as a phosphothreonine lyase; HopPtoD2 from P. syringae is a protein tyrosine phos-
phatase that may target MAPKs. Some plants have evolved the specific intracellular resistance proteins to counteract type III effectors and initiate the
effector-triggered immunity. The resistance proteins are largely encoded by a family of proteins with a nucleotide-binding site and leucine-rich repeat
domain (NB-LRR). The interaction between type III effectors and intracellular NB-LRR proteins could be direct or indirect through other host proteins
(H). The recognition of effectors by plant resistance proteins activates immune responses, including defense gene transcription and programmed cell
death. MAPK signaling cascade may also be activated in plant effector-triggered immunity. Type III effectors from plant pathogens, such as AvrPtoB
and HopPtoD2, could also suppress effector-triggered immunity by blocking cell death. In mammals, PAMPs/MAMPs are recognized by cell-surface
Toll-like receptors (TLR) and intracellular CATERPILLER/NOD-like receptors (NLR). SptP from Salmonella blocks MAPK cascade by interfering with
MAPKKK activation. YopJ, AvrA, and VopA belong to a cysteine protease family. YopJ from Yersinia inhibits both MAPK and NF-kB pathways as an
acetyltransferase with direct binding to MAPKK and IKK; AvrA from Salmonella inhibits the NF-kB pathway downstream of IKK but does not affect the
MAPK pathway; VopA from Vibrio parahaemomolyticus intercepts MAPK signaling with unknown targets but does not suppress the NF-kB pathway.
OspF, a HopAI1 homolog from Shigella, inactivates MAPKs as a phosphothreonine lyase. The inactivation of MAPKs by OspF may occur in the
nucleus, which in turn prevents the phosphorylation of histone H3 and inhibits the transcription of a subset of NF-kB-regulated genes.(Collier-Hyams et al., 2002), whereas VopA blocks MAPK
signaling with unknown targets but not the NF-kB path-
way (Trosky et al., 2004). AvrBsT does not appear to inhibit
flg22-mediatedMAPK activation in plants (He et al., 2006).
Although not yet found in the animal systems, many plants
have evolved disease resistance genes to detect virulence
effectors and trigger potent and secondary innate immune
responses (Figures 2 and 3) (Ausubel, 2005; Chisholm
et al., 2006; Jones and Dangl, 2006).
Notably, a large body of research on effector functions
is based on the overexpression of individual effectors in
host cells. The results from these studies should be inter-
preted with caution, since the secretion process and bio-
logical activities of different effectors are precisely coordi-
nated and temporally regulated. In addition, nonspecific
cellular effects may be obtained by overexpression of172 Cell Host & Microbe 1, May 2007 ª2007 Elsevier Inc.type III effectors that usually express at a very low level.
The understanding of precise functions of individual effec-
tors requires in vivo host-microbe infection assays in the
context of the functions of other effectors and the dynam-
ics of host cellular process. Nevertheless, recent studies
using plant, mammalian, and yeast model systems have
provided tremendous advance and remarkable insights
into the plethora of molecular actions of bacterial type III
effectors. Similar approaches may be applied to study
the functions of effectors delivered into host cells by fungi,
Oomycetes, and other microbes. Manipulation of the evo-
lutionary conserved host signaling pathways, such as
MAPK cascades, reflects a central mechanism used by
bacterial effectors to promote pathogenicity. With the
increase of our knowledge of host immune signaling
and the development of new technologies, research on
Cell Host & Microbe
ReviewTable 1. Examples of Bacterial Effectors Intercepting Host MAPK Signaling Cascades
MAPK Cascade Target Effector (Alias) Organism Biochemical Function Reference
MAPK OspFa Shigella spp. phosphothreonine
lyase
Arbibe et al., 2007;
Kramer et al. 2007;
Li et al., 2007; Zurawski
et al., 2006
HopAI1a Pseudomonas syringae phosphothreonine
lyase
Zhang et al., 2007
HopPtoD2 (HopAO1) Pseudomonas syringae phosphatasec Espinosa et al., 2003
MAPKK YopJb (YopP) Yersinia spp. acetyltransferase Mittal et al., 2006;
Mukherjee et al., 2006
MAPKKK SptP Salmonella spp. tyrosine phosphatase,
GTPase-activating
proteinc
Lin et al., 2003
Upstream MAPKKK AvrPto (AvrPto1) Pseudomonas syringae unknown He et al., 2006
AvrPtoB (HopAB2) Pseudomonas syringae unknown He et al., 2006
Unknown VopAb Vibrio
parahaemomolyticus
unknown Trosky et al., 2004
aOspF, HopAI1, and SpvC (Salmonella spp.) belong to a family based on sequence homology.
b YopJ, VopA, AvrA (Salmonella spp.), and AvrBsT (Xanthomonas campestris pv.vesicatoria) belong to a family of cysteine prote-
ases with conserved catalytic residues.
c The biochemical activities of effectors toward the MAPK cascade components are not known.bacterial pathogenic mechanisms will continue to gener-
ate more exciting breakthroughs.
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